alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER 
Pursuant to 
Section 906 of the Sarbanes-Oxley Act of 2002

I,
Thomas P. Russo, Executive Vice President, Treasurer and Chief Financial
Officer of MetaMorphix, Inc. (the Registrant), certify that to the best of my
knowledge, based upon a review of the annual report on Form 10-KSB/A
(Amendment No. 2) for the year ended December 31, 2006 of the Registrant (the
Report):

| |                                                                                                                                                                  
| | -----------------------------------------------------------------------------------------------------------------------------------------------------------------
| | (1) The
  Report fully complies with the requirements of Section 13(a) or 15(d) of
  the Securities Exchange Act of 1934, as amended; and                        
| |                                                                                                                                                                  
| | (2) The
  information contained in the Report fairly presents, in all material
  respects, the financial condition and results of operations of the
  Registrant.

| |     |                                                                   
| | --- | ------------------------------------------------------------------
| | By: | /S/ THOMAS P. RUSSO                                               
| |     |                                                                   
| |     | Thomas P. Russo                                                   
| |     | Executive Vice President, Treasurer and Chief Financial Officer of
| |     | MetaMorphix, Inc.                                                 

Date: February 29, 2008

---
1

MEP Advisory Board Meeting 

Tuesday, March 7 – Wednesday, March 8, 2023

Information Technology and Innovation Foundation (ITIF)

700 K Steet NW, Suite 600, Washington, DC 20001

AGENDA

Day One: 3/7/2023

1 p.m.-1:30 p.m. 

(30 min)

Welcome and Introductions • Pravina Raghavan, MEP Director

• Video - Gina Raimondo, Secretary of 

Commerce 

• Chair Matthew Newman and Vice Chair

Bernadine Hawes, MEP Advisory Board

1:30 p.m.- 1:45 p.m.

(15 min)

Briefing from Associate Director of 

Innovation and Industry Services

• Mojdeh Bahar, NIST, Associate Director, 

Innovation, and Industry Services

1:45 p.m.- 2:05 p.m.

(20 min)

Director’s Update • Pravina Raghavan, MEP Director

2:05 p.m.-3:10 p.m.

(65 min) 

2023-2027 MEPNN Strategic Plan Overview

and 18-month Metrics

• Pravina Raghavan, MEP Director

• Chair Matthew Newman and Vice Chair 

Bernadine Hawes, MEP Advisory Board

3:10 p.m.-3:20 p.m.

(10 min) 

Welcome/Brief on Information Technology 

Information Foundation

• Rob Atkinson, Founder and President, 

Information Technology and Innovation 

Foundation 

3:20 p.m. – 3:35 p.m.

(15 min) 

Meeting Break

3:35 p.m.— 4:45 p.m.

(70 min)

2023 Working Groups • Pravina Raghavan, MEP Director

• Chair Matthew Newman and Vice Chair 

Bernadine Hawes, MEP Advisory Board

4:45 p.m.-5 p.m.

(15 min)

Day One Wrap Up • Laurie E. Locascio, Director of NIST and the 

Under Secretary of Commerce for Standards 

and Technology (invited)

• Pravina Raghavan, MEP Director

• Carroll Thomas, Senior Advisory, NIST MEP

• Chair Matthew Newman and Vice Chair 

Bernadine Hawes, MEP Advisory Board

Day one meeting adjourns

MAB Board Dinner 6 p.m.
2

AGENDA

Day Two: 3/8/2023

9 a.m.-9:10 a.m. 

(10 min)

Welcome Back • Pravina Raghavan, MEP Director

• Chair Matthew Newman, MEP Advisory Board

9:10 a.m.-10:20 a.m. 

(70 min) 

MEP Expansion Awards Strategy • Pravina Raghavan, MEP Director

• Chair Matthew Newman and Vice Chair 

Bernadine Hawes, MEP Advisory Board

10:20 a.m.-10:40 a.m.

(20 min)

Meeting Break

10:40 a.m-11:10 a.m.

(30 min)

Recognize New Board Leadership • Pravina Raghavan, MEP Director

• Incoming Chair Bernadine Hawes and Vice 

Chair Donald Bockoven, MEP Advisory Board

11:10 a.m. -11:30 a.m.

(20 min)

Public Comments

11:30 a.m.-11:50 a.m.

(20 min)

Meeting Wrap Up • Pravina Raghavan, MEP Director

• Chair Matthew Newman and Vice Chair 

Bernadine Hawes, MEP Advisory Board

Day two meeting adjourns

• Subset of group to participate in NIST OCLA arranged congressional education activity.
Integrated BioTherapeutics, Inc. 

Dr. M. Javad Aman

President and CSO

Integrated BioTherapeutics, Inc. (IBT)
Our Company

Mission

Develop vaccines and therapeutics for infectious agents

Emphasis on:

• Biodefense Market (Filoviruses: Ebola and Marburg)

• Emerging Infectious Diseases (Staph)
Company History

1st License 

Agreement

1st Funding 

TEDCO FDTTI

Lab space

at FITCI 

Founded

DoD Funding

VHF Therapeutics

DoD Funding 

SEB Vaccine

Army SBIR II

SEB Therapeutic

NIH approved 

Clinical Trial

NIH UO1

SEB HuMAb

NIAID, Filovirus 

VLP vaccine
A Growing Maryland Business 

May 2008 

IBT wins Incubator Company of the Year award 

for “Best Life Sciences Company”

June 2008 

-IBT graduates from FITCI business incubator

-IBT moves into Avalon facility in Germantown

May 2009 

The Tech Council of Maryland Awards IBT the 

“Emerging Company of the Year” for the state 

of Maryland
IBT Partnerships: Funding, Collaborations and Partnerships

Funding Support Collaboration
Scientific Platforms

Recombinant Vaccines for Staphylococcal 

and Streptococcal Exotoxins

• STEBVax IND- Biodefense

• SEB-HIG Preclinical-Biodefense

• TSS-HIG Preclinical- Toxic Shock, Sepsis

• SEB-HuMab Preclinical-Biodefense

SEB

HLA-DR

TCR

Virus-Like Particle Vaccines for 

Filoviruses (Ebola & Marburg) 

Arenavirues (Lassa & Junin)

Bunyaviruses (RVFV)
Discovery Pre-clinical Phase I Phase II

Phase III/

Pivotal Studies

FDA

Licensure

Therapeutics Vaccines

FiloVax 

Panfilovirus VLP vaccine 

STEBVax 

Recombinant SEB vaccine 

Multivalent Staph Vaccine

SEB-HIG

HyperImmune Globulin Therapeutic to SEB

TSS-HIG

Toxic shock syndrome Therapeutic

SEB-HuMab

Human Monoclonal Ab Therapeutic

IBT Product Pipeline
NIAID Proposal

IBT was a four person company at the time

Primary Writers:

Dr. Javad Aman – Founder of IBT

Dr. Kelly Warfield (then at USAMRIID) 

IBT’s Advantage: Superior technology and data to show it. 

IBT’s Challenges: Young company/ limited infrastructure

The Solution: Build a team to enhance capabilities

IBT secured a team of subcontractors to win the proposal

Photo by Skip Lawrence
NIAID Contract

Development Plan

Base Period – 4 years, ~ $22 M in funding – Assay Development

– Scale Up and Process Development

– Formulation and Stability

– Bridging, Efficacy, and Immune Correlate Studies

Options Phase - ~43 M in Funding

• cGMP Manufacturing and IND

• Phase I Dose Escalation Safety Clinical Trial

• 200,000 Dose Manufacturing

• Lyophylized Formulation

• Phase II Immunogenicity Clinical Trial
FiloVax Program

• Recognized expertise in Filovirus research

• Very strong technical knowledge of the 

technology and model

• Original inventors of the Army’s Filovirus

VLP Vaccine Candidate

• Ongoing partnership via CRADAs with 

USAMRIID team to develop VLP vaccine
Special Thanks to:

Maryland TEDCO

The National Institute of Allergy and 

Infectious Diseases and NIH
I

105TH CONGRESS

1ST SESSION H. R. 73

To amend section 101 of title 11 of the United States Code to modify

the definition of single asset real estate and to make technical corrections.

IN THE HOUSE OF REPRESENTATIVES

JANUARY 7, 1997

Mr. KNOLLENBERG introduced the following bill; which was referred to the

Committee on the Judiciary

A BILL

To amend section 101 of title 11 of the United States

Code to modify the definition of single asset real estate

and to make technical corrections.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Single Asset Bank5 ruptcy Reform Act of 1997’’.

6 SEC. 2. AMENDMENTS.

7 Section 101 of title 11, United States Code, is amended—

8 (1) in paragraph (51B) by striking ‘‘having’’

9 and all that follows through ‘‘$4,000,000’’,
2

•HR 73 IH

1 (2) in paragraph (35)(B) by striking ‘‘para2 graphs (21B) and (33)(A)’’ and inserting ‘‘para3 graphs (23) and (35)’’,

4 (3) by redesignating paragraphs (4) through

5 (12A) as paragraphs (3) through (12), respectively,

6 and

7 (4) by redesignating paragraphs (21A) through

8 (55) as paragraphs (22) through (66), respectively.

Æ
```

[Congressional Bills 105th Congress]
[From the U.S. Government Publishing Office]
[H.R. 801 Introduced in House (IH)]

105th CONGRESS
  1st Session
                                H. R. 801

   To amend the Federal Meat Inspection Act and the Poultry Products 
Inspection Act to authorize the Secretary of Agriculture to permit the 
 interstate distribution of State-inspected meat and poultry when the 
 Secretary determines that State inspection requirements are at least 
    equal to Federal inspection standards and such requirements are 
                         consistently enforced.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 13, 1997

Mr. Thornberry introduced the following bill; which was referred to the 
                        Committee on Agriculture

_______________________________________________________________________

                                 A BILL

 
   To amend the Federal Meat Inspection Act and the Poultry Products 
Inspection Act to authorize the Secretary of Agriculture to permit the 
 interstate distribution of State-inspected meat and poultry when the 
 Secretary determines that State inspection requirements are at least 
    equal to Federal inspection standards and such requirements are 
                         consistently enforced.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SECRETARIAL AUTHORITY TO REMOVE INTRASTATE DISTRIBUTION 
              RESTRICTION ON STATE-INSPECTED MEAT AND POULTRY.

    (a) Federal Meat Inspection Act.--Section 301(a)(1) of the Federal 
Meat Inspection Act (21 U.S.C. 661(a)(1)) is amended by adding at the 
end the following new sentence: ``If the Secretary determines that a 
State meat inspection program consistently enforces State meat 
inspection requirements that are at least equal to the Federal 
inspection, reinspection, and sanitation requirements under title I of 
this Act, the Secretary may waive the limitation that restricts meat 
and meat food products inspected under that program to intrastate 
distribution.''.
    (b) Poultry Products Inspection Act.--Section 5(a)(1) of the 
Poultry Products Inspection Act (21 U.S.C. 454(a)(1)) is amended by 
adding at the end the following new sentence: ``If the Secretary 
determines that a State poultry product inspection program consistently 
enforces State poultry inspection requirements that are at least equal 
to the Federal inspection, reinspection, and sanitation requirements 
under this Act, the Secretary may waive the limitation that restricts 
poultry and poultry products inspected under that program to intrastate 
distribution.''.
                                 <all>
```
Fourth Court of Appeals

San Antonio, Texas

November 1, 2017

No. 04-17-00667-CV

IN THE INTEREST OF A.E.S., A CHILD,

From the 131st Judicial District Court, Bexar County, Texas

Trial Court No. 2013-PA-02849

Honorable Charles E. Montemayor, Judge Presiding

O R D E R

This is an accelerated appeal of an order terminating the appellant’s parental rights which 

must be disposed of by this court within 180 days of the date the notice of appeal is filed. TEX.

R. JUD. ADMIN. 6.2. The reporter’s record was due to be filed by October 23, 2017. On October 

30, 2017, the court reporter responsible for preparing the record filed a notification of late record 

requesting an extension of time to file the record to November 6, 2017. The notification of late 

record is NOTED. It is ORDERED that the reporter’s record must be filed in this appeal no later 

than November 6, 2017. Given the time constraints governing the disposition of this appeal, 

further requests for extensions of time will be disfavored.

_________________________________

Sandee Bryan Marion, Chief Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 1st day of November, 2017.

___________________________________

KEITH E. HOTTLE,

Clerk of Court
**EXHIBIT 31.2**

 

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

 

I, Paul Kim, certify that: 

 

1.I have reviewed this annual report on Form 10-K of Cogent, Inc.; 

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report; 

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report; 

 

4. Theregistrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: 

 

a) designed such disclosure controls and procedures, orcaused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared; 

 

b) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the endof the period covered by this report based on such evaluation; and 

 

c) discussed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscalquarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internalcontrol over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 

 

a) all significant deficiencies and material weaknesses in the design or operation of internal controls overfinancial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 

b) any fraud, whether or not material, that involves management or other employees who have a significantrole in the registrant’s internal control over financial reporting. 

 

Date: March 22, 2005
Exhibit 32.1

CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350

I,
Don Early, Chief Executive Officer of QC Holdings, Inc. (the Company), hereby certify pursuant to Section 1350, of chapter 63 of title 18, United States Code, and Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best
of my knowledge, (1) the annual report on Form 10-K of the Company to which this Exhibit is attached (the Report) fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934, and (2) the
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|             
|-------------
|/s/ Don Early
|Don Early    

Dated: March 12, 2010

I, Douglas E. Nickerson, Chief Financial Officer of QC Holdings, Inc. (the Company), hereby certify pursuant to Section 1350, of chapter 63
of title 18, United States Code, and Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge, (1) the annual report on Form 10-K of the Company to which this Exhibit is attached (the Report) fully
complies with the requirements of section 13(a) of the Securities Exchange Act of 1934, and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                        
|------------------------
|/s/ Douglas E. Nickerson
|Douglas E. Nickerson    

Dated: March 12, 2010
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 04-6592 CARNELL HUNNICUTT, Plaintiff - Appellant, and UNITED STATES OF AMERICA, Intervenor/Plaintiff,
versus VIRGINIA DEPARTMENT OF CORRECTIONS; R. A. YOUNG; S. K. YOUNG; A. P. HARVEY; T. YATES; R. B. PHILLIPS, Defendants - Appellees, and CHAPLAIN MITCHELL, Defendant.
Appeal from the United States District Court for the Western District of Virginia, at Roanoke. Jackson L. Kiser, Senior District Judge. (CA-01-379-7) Submitted: June 23, 2004 Decided: December 16, 2004- 2 - Before NIEMEYER, MOTZ, and GREGORY, Circuit Judges. Affirmed by unpublished per curiam opinion. Carnell Hunnicutt, Appellant Pro Se. Pamela Anne Sargent, Assistant Attorney General, Susan Foster Barr, OFFICE OF THE ATTORNEY GENERAL OF VIRGINIA, Richmond, Virginia, for Appellees. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).- 3 - PER CURIAM: Carnell Hunnicutt appeals the district court’s order denying relief on his complaint filed under 42 U.S.C. § 1983 (2000) and the Religious Land Use and Institutionalized Persons Act. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. See Hunnicutt v. Virginia Dep’t of Corr. , CA-01-379-7 (W.D. Va. Mar. 19, 2004; Apr. 17, 2003). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.
AFFIRMED
UNITED STATES DISTRICT COURT

FOR THE Northern District of Illinois − CM/ECF LIVE, Ver 6.3.3

Eastern Division

David Summers, et al.

Plaintiff,

v. Case No.: 1:20−cv−03347

Honorable Matthew F. Kennelly

RTI Surgical Holdings, Inc., et al.

Defendant.

NOTIFICATION OF DOCKET ENTRY

This docket entry was made by the Clerk on Friday, September 10, 2021:

 MINUTE entry before the Honorable Matthew F. Kennelly: Telephonic status

hearing held on 9/10/2021 and continued to 9/29/2021 at 9:10 a.m. The following call−in

number will be used for the hearing: 888−684−8852, access code 746−1053. By

9/22/2021, the parties are to either file a status report or a motion for preliminary

approval. Mailed notice. (mma, )

ATTENTION: This notice is being sent pursuant to Rule 77(d) of the Federal Rules of

Civil Procedure or Rule 49(c) of the Federal Rules of Criminal Procedure. It was

generated by CM/ECF, the automated docketing system used to maintain the civil and

criminal dockets of this District. If a minute order or other document is enclosed, please

refer to it for additional information.

For scheduled events, motion practices, recent opinions and other information, visit our

web site at www.ilnd.uscourts.gov.

Case: 1:20-cv-03347 Document #: 69 Filed: 09/10/21 Page 1 of 1 PageID #:681
Fourth Court of Appeals

San Antonio, Texas

May 15, 2019

No. 04-19-00125-CV

EX PARTE A.X.L. JR., a Child

From the 406th Judicial District Court, Webb County, Texas

Trial Court No. 2019FLK00214D4

Honorable Oscar J. Hale, Jr., Judge Presiding

ORDER

In accordance with this court’s opinion of this date, this appeal is DISMISSED FOR 

WANT OF JURISDICTION. Appellant is unable to afford payment of court costs; no costs of 

court are taxed in this appeal.

It is so ORDERED on May 15, 2019.

_____________________________

Patricia O. Alvarez, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 15th day of May, 2019.

_____________________________

Keith E. Hottle, Clerk of Court
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Selective Service System

# AGENCY:

Selective Service System.

# ACTION:

Notice.

The following forms have been submitted to the Office of Management and Budget (OMB) for extension of clearance in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35):

## SSS FORMS 2, 3A, 3B and 3C

*Title:*                     Selective Service System Change of Information, Correction/Change Form, and Registration Status Forms.                

*Purpose:*                     To insure the accuracy and completeness of the Selective Service System registration data.                

*Respondents:*                     Registrants are required to report changes or corrections in data submitted on the SSS Form 1.                

*Frequency:*                     When changes in a registrant's name or address occur.                

*Burden:*                     A burden of two minutes or less on the individual respondent.                

Copies of the above identified forms can be obtained upon written request to the Selective Service System, Reports Clearance Officer, 1515 Wilson Boulevard, Arlington, Virginia 22209-2425.

Written comments and recommendations for the proposed extension of clearance of the form should be sent within 60 days of the publication of this notice to the Selective Service System, Reports Clearance Officer, 1515 Wilson Boulevard, Arlington, Virginia 22209-2425.

A copy of the comments should be sent to the Office of Information and Regulatory Affairs, Attention: Desk Officer, Selective Service System, Office of Management and Budget, New Executive Office Building, Room 3235, Washington, DC 20503.

Dated: November 3, 2014.

Lawrence Romo,

Director.

[FR Doc. 2014-26713 Filed 11-10-14; 8:45 am]

BILLING CODE 8015-01-P